Arrese I, González P, Miranda P, Pérez-Núñez A, Pascual B, Lobato R D
Servicio de Neurocirugía, Hospital Universitario 12 de Octubre, Madrid.
Neurocirugia (Astur). 2005 Apr;16(2):158-68. doi: 10.1016/s1130-1473(05)70421-8.
Gliomas are the most frequent primary tumors of the brain. The standard treatment includes surgery, radiotherapy and chemotherapy, but the outcomes of patients with these tumors have remained nearly unchanged for past years. Hopefully, recent advances in molecular biology are rising new clinical expectation for patients with brain tumors. Among the novel techniques in this new field of research a new field of research, the use of oncolytic viruses has been explored in different trials during last years. In the present review we analyze the advances in the understanding of the oncolytic viral therapy of gliomas.
神经胶质瘤是最常见的原发性脑肿瘤。标准治疗包括手术、放疗和化疗,但这些肿瘤患者的治疗效果在过去几年几乎没有变化。有望的是,分子生物学的最新进展为脑肿瘤患者带来了新的临床期望。在这个新研究领域的新技术中,溶瘤病毒的应用在过去几年的不同试验中得到了探索。在本综述中,我们分析了在神经胶质瘤溶瘤病毒治疗理解方面的进展。